Producatorul de medicamente Onyx Pharma cumpara Proteolix
Onyx Pharmaceuticals cumpara Proteolix, producator de medicamente folosite in tratarea cancerului, iar tranzactia s-ar putea situa in jurul a 851 milioane dolari, potrivit AP.
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2009/10/4ad33f7c9ae04.jpg)
Onyx va plati initial 276 milioane dolari pentru preluarea Proteolix, intrand astfel si in posesia drepturilor pentru medicamentul impotriva cancerului pe baza de carfilzomib, care in acest moment este testat.
Onyx va mai plati 40 milioane de dolari in 2010, daca medicamentul se dovedeste eficace, si alte 535 milioane dolari daca va fi acceptat pe piata din Statele Unite si Europa.
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/themes/strawberry-daily-202207/assets/images/avatar.png){kind=avatar}
Alte articole
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2022/11/banca-centrala-europeana.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/06/DATA-CENTERS.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/06/rammstein-air-base_edited.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/06/Trump_cripto.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/06/munca-de-acasa.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/06/Visa-Payments-Forum.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2026/06/disponibilizari-concedieri-20230-Volkswagen.jpg)
:format(webp):quality(80)/https://www.dailybusiness.ro/wp-content/uploads/2024/12/elevi-1.jpg)
